From Peyton Rous to the HPV Vaccine: A Journey of Discovery and Progress

Affiliations

Comment

H Cody Meissner. Pediatrics. 2019 Dec.

. 2019 Dec;144(6):e20192345.

doi: 10.1542/peds.2019-2345. Epub 2019 Nov 18.

¹ Tufts Medical Center, School of Medicine, Tufts University, Boston, Massachusetts cmeissner@tuftsmedicalcenter.org.

No abstract available

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: The author has indicated he has no potential conflicts of interest to disclose.

Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine.
Donahue JG, Kieke BA, Lewis EM, Weintraub ES, Hanson KE, McClure DL, Vickers ER, Gee J, Daley MF, DeStefano F, Hechter RC, Jackson LA, Klein NP, Naleway AL, Nelson JC, Belongia EA. Donahue JG, et al. Pediatrics. 2019 Dec;144(6):e20191808. doi: 10.1542/peds.2019-1808. Epub 2019 Nov 18. Pediatrics. 2019. PMID: 31740498 Free PMC article.
Safety of the 9-Valent Human Papillomavirus Vaccine.
Shimabukuro TT, Su JR, Marquez PL, Mba-Jonas A, Arana JE, Cano MV. Shimabukuro TT, et al. Pediatrics. 2019 Dec;144(6):e20191791. doi: 10.1542/peds.2019-1791. Epub 2019 Nov 18. Pediatrics. 2019. PMID: 31740500 Free PMC article.